Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA544999
Max Phase: Preclinical
Molecular Formula: C20H23ClN2S
Molecular Weight: 322.48
Molecule Type: Small molecule
Associated Items:
ID: ALA544999
Max Phase: Preclinical
Molecular Formula: C20H23ClN2S
Molecular Weight: 322.48
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccccc1-c1cc2ccccc2nc1SCCN(C)C.Cl
Standard InChI: InChI=1S/C20H22N2S.ClH/c1-15-8-4-6-10-17(15)18-14-16-9-5-7-11-19(16)21-20(18)23-13-12-22(2)3;/h4-11,14H,12-13H2,1-3H3;1H
Standard InChI Key: CBXVEWPEEVRHKT-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 322.48 | Molecular Weight (Monoisotopic): 322.1504 | AlogP: 4.86 | #Rotatable Bonds: 5 |
Polar Surface Area: 16.13 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.47 | CX LogP: 5.27 | CX LogD: 4.17 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.62 | Np Likeness Score: -1.10 |
1. Blackburn TP, Cox B, Guildford AJ, Le Count DJ, Middlemiss DN, Pearce RJ, Thornber CW.. (1987) Synthesis and 5-hydroxytryptamine antagonist activity of 2-[[2-(dimethylamino)ethyl]thio]-3-phenylquinoline and its analogues., 30 (12): [PMID:3681895] [10.1021/jm00395a013] |
Source(1):